A prospective clinical trial to investigate the efficiency and safety of transnasal ileus tube insertion in the laparoscopic radical right colectomy for elderly obstructing colonic cancer

The efficiency and safety of transnasal ileus tube insertion combined with laparoscopic right hemicolectomy in the elderly obstructing right colonic cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200057283

Enrollment

Unknown

Registered

2022-03-06

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Interventions

Experience group (Ileus tube group):Laparoscopic radical right colectomy after ileus tube decompression

Control group 1 (Ileostomy group):Laparoscopic radical right colectomy after ileostomy

Control group 2 (Radical colectomy group):Open radical right colectomy

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 65 years; 2. Symptoms and signs: (1) The presence of pain, vomiting, swelling, closure and other clinical symptoms of intestinal obstruction; (2) Except peritonitis; 3. Chest, abdominal and pelvic CT (plain or plain + enhanced CT) : right colon mass with enlargement of the proximal colon and small intestine; 4. Qualitative diagnosis: adenocarcinoma or other malignant tumors confirmed by postoperative pathological biopsy (otherwise eliminated); 5. Localization diagnosis: The tumor was located in the right 1/3 segment from cecum to transverse colon; 6. ASA grade I-III, TNM stage II-III; 7. Patient or family member, able to understand the study protocol and willing to participate in the study, shall provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Synchronous or heterogeneous multiple primary colorectal cancer; 2. Preoperative imaging examination results showed that: (1) Loop closure ileus, terminal ileum without significant dilation; (2) Vascularized, paralytic or non-tumor mechanical ileus; 3. Preoperative imaging findings: (1) Tumors involving surrounding organs require combined organ resection; (2) Patients with distant organ transfer; 4. Patients with a history of malignant tumor or recurrence of colon cancer; 5. Familial adenomatous polyposis and Lynch syndrome associated colon cancer were excluded; 6. Patients with acute peritonitis caused by gastrointestinal perforation, intestinal bleeding, and intestinal constriction necrosis requiring emergency surgery.

Design outcomes

Primary

Measure	Time frame
Total number of picked lymph nodes;	—

Secondary

Measure	Time frame
Number of positive lymph nodes;Incidence of complications;Disease-free Survival(3y);Overall Survival;	—

Countries

China

Contacts

Public ContactAng Li

Xuanwu Hospital of Capital Medical University

anglixwabc@163.com+86 13701397917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026